| Inflammatory cytokines in general and central obesity and modulating effects of physical activity FM Schmidt, J Weschenfelder, C Sander, J Minkwitz, J Thormann, ... PloS one 10 (3), e0121971, 2015 | 473 | 2015 |
| Cytokines as biomarkers in depressive disorder: current standing and prospects N Lichtblau, FM Schmidt, R Schumann, KC Kirkby, H Himmerich International review of psychiatry 25 (5), 592-603, 2013 | 190 | 2013 |
| Heart rate variability as indicator of clinical state in depression R Hartmann, FM Schmidt, C Sander, U Hegerl Frontiers in psychiatry 9, 431193, 2019 | 185 | 2019 |
| Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity FM Schmidt, N Lichtblau, J Minkwitz, T Chittka, J Thormann, KC Kirkby, ... Journal of psychiatric research 55, 29-34, 2014 | 178 | 2014 |
| Impact of serum cytokine levels on EEG-measured arousal regulation in patients with major depressive disorder and healthy controls FM Schmidt, A Pschiebl, C Sander, KC Kirkby, J Thormann, J Minkwitz, ... Neuropsychobiology 73 (1), 1-9, 2016 | 98 | 2016 |
| Pro-and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression FM Schmidt, T Schröder, KC Kirkby, C Sander, T Suslow, LM Holdt, ... Psychiatry research 239, 85-91, 2016 | 84 | 2016 |
| Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer’s disease FM Schmidt, J Kratzsch, HJ Gertz, M Tittmann, I Jahn, UC Pietsch, ... PloS one 8 (5), e63136, 2013 | 79 | 2013 |
| Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer’s disease FM Schmidt, J Kratzsch, HJ Gertz, M Tittmann, I Jahn, UC Pietsch, ... PloS one 8 (5), e63136, 2013 | 79 | 2013 |
| Inflammation and immune regulation as potential drug targets in antidepressant treatment F M Schmidt, K C Kirkby, N Lichtblau Current neuropharmacology 14 (7), 674-687, 2016 | 73 | 2016 |
| Habenula volume increases with disease severity in unmedicated major depressive disorder as revealed by 7T MRI FM Schmidt, S Schindler, M Adamidis, M Strauß, A Tränkner, R Trampel, ... European archives of psychiatry and clinical neuroscience 267, 107-115, 2017 | 62 | 2017 |
| Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease FM Schmidt, R Mergl, B Stach, I Jahn, HJ Gertz, P Schönknecht Neuroscience letters 570, 81-85, 2014 | 60 | 2014 |
| CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls FM Schmidt, E Arendt, A Steinmetzer, M Bruegel, J Kratzsch, M Strauß, ... Psychiatry research 190 (2-3), 240-243, 2011 | 55 | 2011 |
| Brain arousal regulation as response predictor for antidepressant therapy in major depression FM Schmidt, C Sander, ME Dietz, C Nowak, T Schröder, R Mergl, ... Scientific reports 7 (1), 45187, 2017 | 50 | 2017 |
| Impact of lithium alone and in combination with antidepressants on cytokine production in vitro C Petersein, U Sack, R Mergl, J Schönherr, FM Schmidt, N Lichtblau, ... Journal of neural transmission 122, 109-122, 2015 | 44 | 2015 |
| The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression–report of two cases F M Schmidt, K C Kirkby, H Himmerich Psychiatria Danubina 26 (3), 0-290, 2014 | 44 | 2014 |
| Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder FM Schmidt, R Mergl, B Stach, I Jahn, P Schönknecht The world journal of biological psychiatry 16 (2), 106-113, 2015 | 40 | 2015 |
| Attentional processes during emotional face perception in social anxiety disorder: A systematic review and meta-analysis of eye-tracking findings V Günther, A Kropidlowski, FM Schmidt, K Koelkebeck, A Kersting, ... Progress in neuro-psychopharmacology and biological psychiatry 111, 110353, 2021 | 39 | 2021 |
| Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls FM Schmidt, M Brügel, J Kratzsch, M Strauß, C Sander, P Baum, J Thiery, ... Neuroscience letters 483 (1), 20-22, 2010 | 38 | 2010 |
| Neurobiology of depression and novel antidepressant drug targets N Kern, AJ Sheldrick, FM Schmidt, J Minkwitz Current pharmaceutical design 18 (36), 5791-5801, 2012 | 30 | 2012 |
| Serum markers of inflammation mediate the positive association between neuroticism and depression FM Schmidt, C Sander, J Minkwitz, R Mergl, B Dalton, LM Holdt, ... Frontiers in psychiatry 9, 609, 2018 | 28 | 2018 |
